NCI Shares Surge Over 6% Following Central Huijin's Nomination of Huang Geng as Non-Executive Director Candidate

Stock News
06/12

Shares of NCI (HKEX: 01336) have risen more than 6%, gaining 6.56% to HK$52.05 at the time of writing, with a trading volume of HK$476 million.

The company recently announced that, in accordance with its articles of association, shareholders holding 3% or more of the company's voting shares are entitled to nominate candidates for non-independent directors. As of the announcement date, Central Huijin Investment Ltd. holds 31.34% of the company's shares and has nominated Huang Geng as a candidate for non-executive director on the company's ninth board of directors.

The company's ninth board of directors held its eighth meeting on June 10, 2026, and reviewed and passed a proposal regarding the nomination of Mr. Huang Geng as a candidate for non-executive director on the ninth board. The proposal is now subject to review and approval by the company's shareholders' meeting.

Following approval by the shareholders' meeting, Mr. Huang Geng's appointment as a director will also require final regulatory approval.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10